Get started
Windtree Therapeutics, Inc.Windtree Therapeutics, Inc.Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

WINT chart

Key stats

Market capitalization
‪3.90 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−19.8122USD
Net income
‪−39.21 M‬USD
Revenue
—
Shares float
‪7.38 M‬
Beta (1Y)
1.15

About Windtree Therapeutics, Inc.

Sector
Health Technology
CEO
Craig E. Fraser
Headquarters
Warrington
Website
windtreetx.com
Employees (FY)
20
Founded
1992
ISIN
US97382D4025
FIGI
BBG000JMNPX3
Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of WINT is 0.42 USD — it has decreased by 0.66% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Windtree Therapeutics, Inc. stocks are traded under the ticker WINT.
Windtree Therapeutics, Inc. is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
WINT earnings for the last quarter are −0.86 USD whereas the estimation was −0.63 USD which accounts for −36.51% surprise. Estimated earnings for the next quarter are −0.94 USD. See more details about Windtree Therapeutics, Inc. earnings.
Windtree Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of ‪200.00 K‬ USD. In the next quarter revenue is expected to reach ‪50.00 K‬ USD.
Yes, you can track Windtree Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, WINT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Windtree Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
WINT reached its all-time high on Mar 1, 1996 with the price of 9922500.00 USD, and its all-time low was 0.28 USD and was reached on Feb 22, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 20.00 employees. See our rating of the largest employees — is Windtree Therapeutics, Inc. on this list?